15 minutes delayed
Comments
Loading...
Sio Gene Therapies Inc (OTC:SIOX) Stock, Earnings Estimates, EPS, And Revenue
Sio Gene Therapies Inc reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 14
EPS
$-0.050
Quarterly Revenue
$0K
Annual Revenue
–
Analyze the earnings history of Sio Gene Therapies Inc using advanced sorting and filters.
Data brought to you by Benzinga APIs
Sio Gene Therapies Inc (SIOX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2022 | 2022-08-11 | $-0.11 | $-0.19 | 42.1 % |
| Mar 2022 | 2022-06-14 | $-0.18 | $-0.20 | 10.0 % |
| Dec 2021 | 2022-02-11 | $-0.35 | $-0.22 | -59.1 % |
| Sep 2021 | 2021-11-12 | $-0.29 | $-0.17 | -70.6 % |
Sio Gene Therapies Inc (SIOX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Sio Gene Therapies Inc (OTC:SIOX) reporting earnings?
Sio Gene Therapies Inc ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 14, 2023 for Q3.
What were the latest earnings per share (EPS) for Sio Gene Therapies Inc (OTC:SIOX)?
Sio Gene Therapies Inc ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 14, 2023 for Q3 and the Actual EPS was $-0.05, which missed the estimate of $0.00.
What were Sio Gene Therapies Inc’s (OTC:SIOX) revenues?
Sio Gene Therapies Inc ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 14, 2023 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.